Lastest Insider Transactions Of GenMark Diagnostics, Inc. ( GNMK ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-02-23 | Sell | 266 | 19.16 | 5,097 | 2021-02-25 18:33:45 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2021-02-23 | Sell | 3,895 | 19.20 | 74,802 | 2021-02-25 18:32:35 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2021-02-23 | Sell | 425 | 19.21 | 8,164 | 2021-02-25 18:32:05 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-02-22 | Sell | 163 | 19.12 | 3,117 | 2021-02-24 18:04:53 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2021-02-18 | Sell | 654 | 21.80 | 14,257 | 2021-02-22 19:04:13 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2021-02-18 | Sell | 2,340 | 21.80 | 51,012 | 2021-02-22 19:03:11 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-02-18 | Sell | 290 | 20.36 | 5,904 | 2021-02-22 19:02:03 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-02-18 | Sell | 500 | 21.68 | 10,840 | 2021-02-22 18:59:18 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-02-04 | Sell | 500 | 14.69 | 7,345 | 2021-02-08 17:10:47 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-01-26 | Sell | 6,214 | 15.19 | 94,391 | 2021-01-29 17:16:22 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-01-27 | Sell | 322 | 14.06 | 4,527 | 2021-01-29 17:16:06 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2021-01-27 | Sell | 81 | 14.06 | 1,139 | 2021-01-29 17:15:07 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2021-01-27 | Sell | 1,117 | 14.06 | 15,705 | 2021-01-29 17:14:43 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2021-01-27 | Sell | 783 | 14.06 | 11,009 | 2021-01-29 17:14:22 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2021-01-21 | Sell | 33,027 | 14.22 | 469,644 | 2021-01-25 20:37:31 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2021-01-21 | Option Exercise | 83,836 | 0.00 | 0 | 2021-01-25 20:37:31 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-01-21 | Sell | 21,453 | 14.25 | 305,626 | 2021-01-25 20:37:14 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-01-21 | Option Exercise | 56,864 | 0.00 | 0 | 2021-01-25 20:37:14 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2021-01-21 | Sell | 10,317 | 14.22 | 146,708 | 2021-01-25 20:36:41 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2021-01-21 | Option Exercise | 27,511 | 0.00 | 0 | 2021-01-25 20:36:41 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2021-01-21 | Sell | 18,475 | 14.24 | 263,084 | 2021-01-25 20:36:24 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2021-01-21 | Option Exercise | 50,449 | 0.00 | 0 | 2021-01-25 20:36:24 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2021-01-21 | Sell | 7,338 | 14.22 | 104,346 | 2021-01-25 20:36:07 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2021-01-21 | Option Exercise | 19,166 | 0.00 | 0 | 2021-01-25 20:36:07 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2021-01-21 | Sell | 29,658 | 14.22 | 421,737 | 2021-01-25 20:35:49 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2021-01-21 | Option Exercise | 77,240 | 0.00 | 0 | 2021-01-25 20:35:49 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-01-25 | Sell | 23,764 | 14.22 | 337,924 | 2021-01-25 20:35:32 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2021-01-25 | Sell | 64,975 | 14.23 | 924,594 | 2021-01-25 20:35:15 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-01-20 | Sell | 5,000 | 15.00 | 75,000 | 2021-01-22 18:25:51 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2021-01-20 | Option Exercise | 65,185 | 0.00 | 0 | 2021-01-22 18:25:51 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2021-01-19 | Sell | 50,000 | 14.54 | 727,000 | 2021-01-21 20:09:53 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2021-01-19 | Option Exercise | 146,172 | 0.00 | 0 | 2021-01-21 20:09:53 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-01-06 | Sell | 49,300 | 16.65 | 820,952 | 2021-01-08 18:01:41 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2021-01-06 | Option Exercise | 31,500 | 11.96 | 376,665 | 2021-01-08 18:01:41 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-12-24 | Sell | 500 | 15.00 | 7,500 | 2020-12-29 18:32:38 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-12-21 | Sell | 15,000 | 15.00 | 225,000 | 2020-12-22 17:42:51 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-12-10 | Sell | 500 | 12.79 | 6,395 | 2020-12-11 17:51:17 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2020-12-07 | Sell | 274 | 13.97 | 3,828 | 2020-12-09 17:24:19 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-11-27 | Sell | 500 | 12.42 | 6,210 | 2020-12-01 17:48:22 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-11-24 | Sell | 1,418 | 13.17 | 18,675 | 2020-11-25 17:30:15 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-11-24 | Sell | 5,190 | 13.17 | 68,352 | 2020-11-25 17:29:57 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2020-11-24 | Sell | 355 | 13.17 | 4,675 | 2020-11-25 17:29:43 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-11-24 | Sell | 1,132 | 13.17 | 14,908 | 2020-11-25 17:29:22 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-11-24 | Sell | 3,234 | 13.17 | 42,592 | 2020-11-25 17:28:48 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-11-24 | Sell | 2,512 | 13.17 | 33,083 | 2020-11-25 17:28:25 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-11-25 | Sell | 552 | 12.72 | 7,021 | 2020-11-25 17:28:05 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-11-20 | Sell | 2,360 | 13.15 | 31,023 | 2020-11-24 19:53:50 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-11-19 | Sell | 1,637 | 13.85 | 22,672 | 2020-11-20 18:10:38 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-11-19 | Sell | 1,637 | 13.85 | 22,672 | 2020-11-20 18:10:20 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-11-19 | Sell | 1,310 | 13.85 | 18,144 | 2020-11-20 18:10:04 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-11-19 | Sell | 1,555 | 13.85 | 21,537 | 2020-11-20 18:09:48 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-11-19 | Sell | 3,987 | 13.85 | 55,220 | 2020-11-20 18:09:32 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-11-19 | Sell | 656 | 13.85 | 9,086 | 2020-11-20 18:09:15 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-11-19 | Sell | 1,146 | 13.85 | 15,872 | 2020-11-20 18:08:55 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-11-11 | Sell | 59,293 | 12.77 | 757,172 | 2020-11-13 17:35:11 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-11-12 | Sell | 500 | 13.68 | 6,840 | 2020-11-13 17:34:55 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2020-10-27 | Sell | 1,092 | 11.34 | 12,383 | 2020-10-29 18:12:02 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2020-10-27 | Sell | 68 | 11.34 | 771 | 2020-10-29 18:09:34 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-10-27 | Sell | 720 | 11.33 | 8,155 | 2020-10-29 18:07:49 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-10-27 | Sell | 765 | 11.34 | 8,675 | 2020-10-29 18:06:36 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-10-15 | Sell | 500 | 11.83 | 5,915 | 2020-10-16 17:01:55 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-10-07 | Sell | 69,749 | 15.00 | 1,046,235 | 2020-10-09 18:35:34 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-10-07 | Option Exercise | 58,680 | 12.76 | 748,786 | 2020-10-09 18:35:34 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-10-01 | Sell | 500 | 14.46 | 7,230 | 2020-10-02 19:37:09 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-09-22 | Sell | 41,196 | 13.82 | 569,329 | 2020-09-24 17:58:15 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-09-16 | Sell | 5,723 | 12.98 | 74,285 | 2020-09-18 17:40:50 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-09-17 | Sell | 500 | 12.72 | 6,360 | 2020-09-18 17:39:34 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2020-09-08 | Sell | 285 | 11.02 | 3,141 | 2020-09-10 18:14:02 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-09-08 | Sell | 4,000 | 11.02 | 44,080 | 2020-09-10 17:45:09 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-09-03 | Sell | 500 | 12.20 | 6,100 | 2020-09-04 17:44:24 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-08-27 | Sell | 891 | 13.10 | 11,672 | 2020-08-28 17:54:04 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-08-26 | Sell | 50,000 | 15.02 | 751,000 | 2020-08-28 17:53:01 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-08-25 | Sell | 5,547 | 14.51 | 80,513 | 2020-08-26 18:32:44 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-08-25 | Sell | 4,532 | 14.14 | 64,082 | 2020-08-26 18:30:44 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-08-25 | Sell | 2,684 | 14.14 | 37,952 | 2020-08-26 18:29:38 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-08-25 | Sell | 2,130 | 14.14 | 30,118 | 2020-08-26 18:28:39 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-08-25 | Sell | 1,211 | 14.14 | 17,124 | 2020-08-26 18:27:28 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-08-25 | Sell | 1,515 | 14.14 | 21,422 | 2020-08-26 18:18:07 |
GNMK | GenMark Diagnostics, Inc. | Shaw Christine | VP, Assay Development | 2020-08-25 | Sell | 379 | 14.14 | 5,359 | 2020-08-26 18:17:10 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-08-25 | Sell | 2,904 | 14.14 | 41,063 | 2020-08-26 18:15:38 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-08-20 | Sell | 1,691 | 15.41 | 26,058 | 2020-08-24 19:37:46 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-08-20 | Sell | 2,988 | 15.41 | 46,045 | 2020-08-24 18:13:07 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-08-20 | Sell | 1,353 | 15.41 | 20,850 | 2020-08-24 18:12:05 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-08-20 | Sell | 4,688 | 15.54 | 72,871 | 2020-08-24 18:11:51 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-08-20 | Sell | 677 | 15.41 | 10,433 | 2020-08-24 18:10:24 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-08-20 | Sell | 1,606 | 15.41 | 24,748 | 2020-08-24 18:08:38 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-08-20 | Sell | 1,184 | 15.41 | 18,245 | 2020-08-24 18:07:18 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-08-20 | Sell | 2,591 | 15.60 | 40,431 | 2020-08-24 18:07:11 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-08-18 | Sell | 45,301 | 15.52 | 703,210 | 2020-08-20 18:15:13 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-08-14 | Sell | 33,377 | 15.98 | 533,314 | 2020-08-18 18:09:58 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-08-12 | Sell | 50,000 | 15.08 | 754,000 | 2020-08-14 18:06:58 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-08-04 | Sell | 621 | 18.93 | 11,756 | 2020-08-05 19:23:12 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-08-03 | Sell | 4,000 | 17.92 | 71,680 | 2020-08-03 18:39:09 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-07-28 | Sell | 212 | 17.30 | 3,668 | 2020-07-29 19:09:49 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2020-07-28 | Sell | 1,052 | 17.30 | 18,200 | 2020-07-29 19:03:46 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-07-28 | Sell | 737 | 17.30 | 12,750 | 2020-07-29 19:01:39 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-07-01 | Sell | 4,000 | 14.45 | 57,800 | 2020-07-02 18:28:36 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-06-01 | Sell | 4,000 | 9.72 | 38,880 | 2020-06-02 18:04:00 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-28 | Sell | 2,021 | 9.52 | 19,240 | 2020-06-01 17:19:14 |
GNMK | GenMark Diagnostics, Inc. | Ek John Frederick | Chief Financial Officer | 2020-05-28 | Sell | 1,460 | 9.52 | 13,899 | 2020-06-01 17:15:38 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-05-28 | Sell | 1,168 | 9.52 | 11,119 | 2020-06-01 17:13:12 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affairs | 2020-05-28 | Sell | 2,066 | 9.52 | 19,668 | 2020-06-01 17:11:01 |
GNMK | GenMark Diagnostics, Inc. | Mendel Scott | President & CEO | 2020-05-28 | Sell | 3,751 | 9.52 | 35,710 | 2020-06-01 17:08:11 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-05-28 | Sell | 2,602 | 9.52 | 24,771 | 2020-06-01 17:03:46 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-05-28 | Sell | 2,815 | 9.52 | 26,799 | 2020-06-01 16:59:12 |
GNMK | GenMark Diagnostics, Inc. | Maderazo Alan Baer | VP, Qual, Reg, & Clin Affaiirs | 2020-05-19 | Sell | 1,319 | 10.46 | 13,797 | 2020-05-20 18:12:28 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-19 | Sell | 2,131 | 10.46 | 22,290 | 2020-05-20 18:10:21 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-19 | Sell | 2,131 | 10.46 | 22,290 | 2020-05-20 18:10:21 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-19 | Sell | 2,131 | 10.46 | 22,290 | 2020-05-20 18:10:21 |
GNMK | GenMark Diagnostics, Inc. | Stier Eric | SVP & General Counsel | 2020-05-19 | Sell | 1,566 | 10.46 | 16,380 | 2020-05-20 17:59:05 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-05-19 | Sell | 661 | 10.46 | 6,914 | 2020-05-20 17:57:36 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-05-19 | Sell | 1,648 | 10.46 | 17,238 | 2020-05-20 17:56:03 |
GNMK | GenMark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | 2020-05-19 | Sell | 1,648 | 10.46 | 17,238 | 2020-05-20 17:56:03 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-05 | Sell | 703 | 13.49 | 9,483 | 2020-05-06 17:29:47 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-05-01 | Sell | 4,000 | 12.44 | 49,760 | 2020-05-04 17:10:45 |
GNMK | GenMark Diagnostics, Inc. | Harkins Michael John | SVP, Sales | 2020-04-29 | Sell | 4,124 | 11.64 | 48,003 | 2020-05-01 18:12:08 |
GNMK | GenMark Diagnostics, Inc. | FAULKNER DARYL | Directior | 2020-04-29 | Option Exercise | 14,450 | 6.00 | 86,700 | 2020-05-01 18:08:21 |
GNMK | GenMark Diagnostics, Inc. | Jensen Tyler | SVP, Engineering and Tech Dev | 2020-04-29 | Sell | 830 | 11.64 | 9,661 | 2020-05-01 18:06:41 |
GNMK | GenMark Diagnostics, Inc. | Winkler Sarah Hollis | VP, Human Resources | 2020-04-29 | Sell | 726 | 11.64 | 8,451 | 2020-05-01 18:02:29 |
GNMK | GenMark Diagnostics, Inc. | Fox James | Directior | 2020-03-06 | Buy | 9,000 | 5.50 | 49,500 | 2020-03-10 11:44:00 |
GNMK | GenMark Diagnostics, Inc. | OBOYLE KEVIN C | Directior | 2020-03-06 | Buy | 10,800 | 4.53 | 48,924 | 2020-03-09 11:22:22 |
GNMK | GenMark Diagnostics, Inc. | Kagnoff Michael | Directior | 2020-03-04 | Buy | 10,000 | 4.61 | 46,100 | 2020-03-05 11:44:00 |
GNMK | GenMark Diagnostics, Inc. | Mitchell Brian Andrew | SVP, Operations | 2020-03-02 | Sell | 2,000 | 3.50 | 7,000 | 2020-03-03 17:28:34 |